Centrus Energy Corp. (LEU)

NYSEEnergyUraniumSnapshot 2026-10-23

$102.45-1.63%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Centrus Energy Corp.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+14.6% · beyond scale

+10% or more+5%0%−5%−10% or less

2.88 → 3.30 EPS · FY ending Dec 31, 2027 · 8 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 11 to 8; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	168.06M
EPS	—	1.236
FY 2026 · Annual
Revenue	$450M–$500M	477.4M
Upward revised revenue	$450M–$500M	—
EPS	—	2.476
FY 2027 · Annual
Revenue	—	490.78M
EPS	—	3.304

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Capital spending of $350M to $500M in 2026	A supporting condition in Centrus Energy Corp.'s published investment case. The stated target is $350M to $500M.	Intact	Capital spending falls below $350M in FY26	Capital expenditures: $71.6M FY2026-Q2; GAAP. Published target: $350M to $500M. Target period is not explicitly aligned with this observation. Source published Aug 6, 202671,600,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Progress on uranium enrichment facility expansion	It is expanding its uranium enrichment plant in Ohio.	Improving	Expansion progress stalls or reverses in next 12 months	qualitative progress vs 12-month target News confirms centrifuge manufacturing and strategic acquisition supporting facility expansion objectives. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue of $450M to $500M in 2026	A primary condition in Centrus Energy Corp.'s published investment case. The stated target is $450M to $500M.	Intact	Revenue falls below $450M in FY26	Revenue: $176.1M FY2026-Q2; GAAP. Published target: $450M to $500M. Target period is not explicitly aligned with this observation. Source published Aug 6, 2026176,100,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: ff19cab6-39dd-40e0-8c4b-dba004214962. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$3.30

$3.94 → $3.30 · observed estimates

FY2027 revenue$0.49B

$0.50B → $0.49B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$3.94	$497,497,520	6 / 14
2026-07-25	$4.17	$497,497,520	7 / 14
2026-07-26	$2.94	$498,326,680	10 / 11
2026-07-27	$2.94	$498,326,680	10 / 11
2026-07-28	$2.94	$498,326,680	10 / 11
2026-07-29	$5.02	$502,913,780	5 / 12
2026-07-30	$5.02	$502,913,780	5 / 12
2026-07-31	Unavailable	$497,992,660	4 / 12
2026-08-01	$2.85	$487,676,680	9 / 10
2026-08-02	$4.51	$497,992,660	5 / 12
2026-08-03	$4.51	$497,992,660	5 / 12
2026-08-04	$4.51	$497,992,660	5 / 12
2026-08-05	$4.51	$497,992,660	5 / 12
2026-08-06	$2.66	$483,519,616	9 / 10
2026-08-07	$2.74	$483,491,044	10 / 10
2026-08-08	$3.63	$472,780,150	9 / 15
2026-08-09	$2.74	$483,491,044	10 / 10
2026-08-10	$2.74	$483,491,044	10 / 10
2026-08-12	$3.75	$471,521,750	9 / 15
2026-08-13	$3.75	$471,521,750	9 / 15
2026-08-14	$2.74	$483,491,044	10 / 10
2026-08-15	$2.74	$483,491,044	11 / 11
2026-08-16	$2.74	$483,491,044	11 / 11
2026-08-17	$2.74	$483,491,044	11 / 11
2026-08-18	$2.74	$483,491,044	11 / 11
2026-08-19	$2.74	$483,491,044	11 / 11
2026-08-20	$2.87	$471,500,539	11 / 11
2026-08-21	$2.87	$471,500,539	11 / 11
2026-08-22	$2.87	$471,500,539	11 / 11
2026-08-23	$2.87	$471,500,539	11 / 11
2026-08-24	$2.87	$471,500,539	11 / 11
2026-08-25	$2.89	$470,173,873	11 / 11
2026-08-26	$2.89	$470,173,873	11 / 11
2026-08-27	$2.89	$470,173,873	11 / 11
2026-08-28	$2.89	$470,173,873	11 / 11
2026-08-29	$2.90	$468,138,199	11 / 11
2026-08-30	$2.90	$468,138,199	11 / 11
2026-08-31	$2.90	$468,138,199	11 / 11
2026-09-01	$2.90	$468,138,199	11 / 11
2026-09-02	$2.90	$468,138,199	11 / 11
2026-09-03	$2.90	$468,138,199	11 / 11
2026-09-04	$2.90	$470,442,062	11 / 11
2026-09-05	$2.90	$470,442,062	11 / 11
2026-09-06	$2.85	$466,866,389	11 / 12
2026-09-07	$2.85	$466,866,389	11 / 12
2026-09-08	$2.85	$466,866,389	11 / 12
2026-09-09	$2.85	$466,866,389	11 / 12
2026-09-10	$2.85	$466,866,389	11 / 12
2026-09-11	$2.85	$466,866,389	11 / 12
2026-09-12	$2.88	$466,866,389	11 / 12
2026-09-13	$2.88	$466,866,389	11 / 12
2026-09-14	$2.88	$466,866,389	11 / 12
2026-09-15	$2.88	$466,866,389	11 / 12
2026-09-16	$2.88	$466,866,389	11 / 12
2026-09-17	$2.88	$466,866,389	11 / 12
2026-09-18	$2.88	$466,866,389	11 / 12
2026-09-19	$2.88	$466,866,389	11 / 12
2026-09-20	$2.88	$466,866,389	11 / 12
2026-09-21	$2.88	$466,866,389	11 / 12
2026-09-22	$2.88	$466,866,389	11 / 12
2026-09-23	$2.88	$466,866,389	11 / 12
2026-09-24	$2.88	$466,866,389	11 / 12
2026-09-25	$2.88	$466,866,389	9 / 12
2026-09-26	$2.88	$466,866,389	9 / 12
2026-09-27	$2.88	$466,866,389	9 / 12
2026-09-28	$2.88	$466,866,389	9 / 12
2026-09-29	$2.88	$466,866,389	9 / 12
2026-09-30	$2.88	$466,866,389	9 / 12
2026-10-01	$2.88	$466,866,389	9 / 12
2026-10-02	$2.88	$466,866,389	9 / 12
2026-10-03	$2.88	$466,866,389	9 / 12
2026-10-04	$2.88	$466,866,389	9 / 12
2026-10-05	$2.88	$466,866,389	9 / 12
2026-10-06	$2.88	$466,866,389	9 / 12
2026-10-07	$2.88	$466,866,389	9 / 12
2026-10-08	$2.88	$466,866,389	9 / 12
2026-10-09	$2.85	$470,443,490	9 / 12
2026-10-10	$2.85	$470,443,490	9 / 12
2026-10-11	$2.86	$470,443,490	9 / 12
2026-10-12	$2.86	$470,443,490	9 / 12
2026-10-13	$2.86	$470,443,490	9 / 12
2026-10-14	$2.86	$470,443,490	9 / 12
2026-10-15	$2.86	$470,443,490	9 / 12
2026-10-16	$2.86	$470,443,490	9 / 12
2026-10-17	$2.86	$470,443,490	9 / 12
2026-10-18	$2.86	$470,443,490	9 / 12
2026-10-19	$2.86	$470,443,490	9 / 12
2026-10-20	$2.86	$470,443,490	9 / 12
2026-10-21	$2.86	$470,443,490	9 / 12
2026-10-22	$3.19	$490,772,105	8 / 12
2026-10-23	$3.33	$490,777,988	8 / 12
2026-10-24	$3.30	$490,780,341	8 / 12

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	11	5
2026-06-01	11	5
2026-07-01	12	5
2026-08-01	12	6
2026-09-01	12	7
2026-10-01	12	7

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 12 Buy / Strong Buy · 7 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades5 maintains

Recent actions · Sep 25–Oct 24 · 5 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

UBSOct 23 · prior Aug 19

$185.00 → $120.00-35.1%

Truist FinancialOct 22 · prior Jul 13

$215.00 → $178.00-17.2%

BarclaysOct 22 · prior Aug 18

$207.00 → $150.00-27.5%

Roth CapitalOct 20 · prior Aug 6

$188.00 → $115.00-38.8%

NeedhamOct 20 · prior Jul 9

$264.00 → $206.00-22.0%

GuggenheimOct 8

$167.00New observation · no comparable prior

$0$145.20$290.40

0 raises · 5 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Capital spending of $350M to $500M in 2026Capital expenditures: $71.6M
Revenue of $450M to $500M in 2026Revenue: $176.1M

Next proof point

Nov 4, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

3.5%Typical daily move · historical

Downside history

-73.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Centrus Energy Corp. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a high-risk capacity-expansion story with a supportive sector backdrop, rather than a mature, steady compounder. The long-term thesis is intact but on watch: capacity and customer work show progress, while earnings quality is fragile and management execution has been volatile.

What's priced into Centrus Energy Corp.

LEU is valued at a substantial premium to peers, and the valuation reading has risen recently. The evidence points to a durable premium, but the expectations gap is modest and model confidence is low, so the market appears to assume continued progress without the evidence showing that all execution risks are priced in.

What the fundamentals likely do

Near term, results may remain uneven: revenue and operating income rose from the first to the second quarter of 2026, but full-year revenue guidance has not yet been confirmed by reported results. Management has made progress on customer contracts and expansion plans, while the capacity build-out and planned capital spending remain in progress; a guidance cut would be a meaningful setback.

What Centrus Energy Corp. hinges on

Over the next few years, the thesis depends on turning commercial agreements into delivered revenue and expanding domestic LEU and HALEU enrichment capacity. Near term, guidance on the next call is a key swing factor, while UEC’s earnings and guidance may signal whether the sector tailwind is strengthening or fading.